These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34520823)

  • 1. PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells.
    Bluemel G; Planque M; Madreiter-Sokolowski CT; Haitzmann T; Hrzenjak A; Graier WF; Fendt SM; Olschewski H; Leithner K
    Free Radic Biol Med; 2021 Nov; 176():34-45. PubMed ID: 34520823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
    Vincent EE; Sergushichev A; Griss T; Gingras MC; Samborska B; Ntimbane T; Coelho PP; Blagih J; Raissi TC; Choinière L; Bridon G; Loginicheva E; Flynn BR; Thomas EC; Tavaré JM; Avizonis D; Pause A; Elder DJ; Artyomov MN; Jones RG
    Mol Cell; 2015 Oct; 60(2):195-207. PubMed ID: 26474064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.
    Leithner K; Hrzenjak A; Trötzmüller M; Moustafa T; Köfeler HC; Wohlkoenig C; Stacher E; Lindenmann J; Harris AL; Olschewski A; Olschewski H
    Oncogene; 2015 Feb; 34(8):1044-50. PubMed ID: 24632615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
    Smolle E; Leko P; Stacher-Priehse E; Brcic L; El-Heliebi A; Hofmann L; Quehenberger F; Hrzenjak A; Popper HH; Olschewski H; Leithner K
    Mol Oncol; 2020 Nov; 14(11):2853-2867. PubMed ID: 32777161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death.
    Zhang J; He W; Liu D; Zhang W; Qin H; Zhang S; Cheng A; Li Q; Wang F
    Front Pharmacol; 2024; 15():1434988. PubMed ID: 39193344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway.
    Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ
    Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.
    Leithner K; Triebl A; Trötzmüller M; Hinteregger B; Leko P; Wieser BI; Grasmann G; Bertsch AL; Züllig T; Stacher E; Valli A; Prassl R; Olschewski A; Harris AL; Köfeler HC; Olschewski H; Hrzenjak A
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6225-6230. PubMed ID: 29844165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability.
    Méndez-Lucas A; Hyroššová P; Novellasdemunt L; Viñals F; Perales JC
    J Biol Chem; 2014 Aug; 289(32):22090-102. PubMed ID: 24973213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells.
    de Zeeuw P; Treps L; García-Caballero M; Harjes U; Kalucka J; De Legher C; Brepoels K; Peeters K; Vinckier S; Souffreau J; Bouché A; Taverna F; Dehairs J; Talebi A; Ghesquière B; Swinnen J; Schoonjans L; Eelen G; Dewerchin M; Carmeliet P
    Commun Biol; 2024 May; 7(1):618. PubMed ID: 38783087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.
    Luo S; Li Y; Ma R; Liu J; Xu P; Zhang H; Tang K; Ma J; Liu N; Zhang Y; Sun Y; Ji T; Liang X; Yin X; Liu Y; Tong W; Niu Y; Wang N; Wang X; Huang B
    Oncogene; 2017 Jun; 36(25):3609-3617. PubMed ID: 28166201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?
    Grasmann G; Smolle E; Olschewski H; Leithner K
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):24-36. PubMed ID: 31152822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic pathogenic variants in the mitochondrial form of phosphoenolpyruvate carboxykinase cause peripheral neuropathy.
    Sondheimer N; Aleman A; Cameron J; Gonorazky H; Sabha N; Oliveira P; Amburgey K; Wahedi A; Wang D; Shy M; Dowling JJ
    HGG Adv; 2023 Apr; 4(2):100182. PubMed ID: 36845668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth.
    Balsa-Martinez E; Puigserver P
    Mol Cell; 2015 Nov; 60(4):509-11. PubMed ID: 26590709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate Kinase Isozyme 3 Regulates Mitochondrial Energy Metabolism and Knockout Alters HeLa Cell Metabolism.
    Fujisawa K; Wakazaki M; Matsuzaki A; Matsumoto T; Yamamoto N; Noma T; Takami T
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis.
    Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y
    Cell Signal; 2024 Aug; 120():111198. PubMed ID: 38697449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency.
    Li Z; Yue M; Heng BC; Liu Y; Zhang P; Zhou Y
    Int J Oral Sci; 2022 Nov; 14(1):54. PubMed ID: 36376276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pck-ing up steam: Widening the salmonid gluconeogenic gene duplication trail.
    Marandel L; Kostyniuk DJ; Best C; Forbes JLI; Liu J; Panserat S; Mennigen JA
    Gene; 2019 May; 698():129-140. PubMed ID: 30849535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y
    Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation-induced PCK isoenzyme transition promotes metabolic adaption of liver cancer to systemic therapy.
    Jing Z; Gao J; Li J; Niu F; Tian L; Nan P; Sun Y; Xie X; Zhu Y; Zhao Y; Liu F; Zhou L; Sun Y; Zhao X
    Cancer Lett; 2021 Oct; 519():46-62. PubMed ID: 34166767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cells.
    Jeon JY; Lee H; Park J; Lee M; Park SW; Kim JS; Lee M; Cho B; Kim K; Choi AM; Kim CK; Yun M
    Biochem Biophys Res Commun; 2015 Jul; 463(3):440-6. PubMed ID: 26036577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.